ClinicalTrials.Veeva

Menu

Efficacy of the Nanodropper Device on Pupillary Dilation

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Dilation

Treatments

Device: Nanodropper
Device: Standard Eye Dropper

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05274321
20-32530-OBS

Details and patient eligibility

About

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.

Enrollment

50 patients

Sex

All

Ages

2 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants under the age of 18 years old

Exclusion criteria

  • Participants 18 years and older
  • Pupillary or anterior segment abnormality
  • Participants with pre-existing health conditions that would prevent pupillary dilation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Pediatric Participant's Eyes Using Standard Pupilary Dilation
Active Comparator group
Description:
Consenting pediatric participants will undergo standard pupillary dilation in one eye.
Treatment:
Device: Standard Eye Dropper
Pediatric Participant's Eyes using Nanodropper attachment
Experimental group
Description:
Consenting pediatric participants will undergo pupillary dilation in the second eye using the Nanodropper attachment.
Treatment:
Device: Nanodropper

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems